programm [ H2020 ]  otsingusõna [ STELLENBOSCH UNIVERSITY ]

  « tagasi projektide nimekirja lehele

Establishing innovative approaches for optimal infection prevention of resistant bacteria in NICUs by integrating research, implementation science and surveillance in a sustainable global platform

akronüüm: NeoIPC
algus: 2021-04-01
lõpp: 2026-03-31
 
programm: H2020 - Horisont 2020
alaprogramm: HEALTH - Tervishoid, demograafilised muutused ja heaolu
instrument: RIA
projektikonkurss: H2020-SC1-2020-Single-Stage-RTD
projekti number: 965328
kestus kuudes: 60
partnerite arv: 13
 
lühikokkuvõte: Around 10% of newborns in Europe will be admitted to a neonatal intensive care unit (NICU). Critically ill babies are a highly vulnerable population for the acquisition of resistant bacteria. Sepsis is among the most common events in NICU and is known to
partneri jrk nr ja roll partneri nimi riik kontaktisik koduleht
1 koordinaator UNIVERSITA DEGLI STUDI DI PADOVA IT Eugenio Baraldi www.unipd.it
2 partner ST GEORGE'S HOSPITAL MEDICAL SCHOOL UK www.sgul.ac.uk
3 partner UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL www.umcutrecht.nl
4 partner UNIVERSITAT ZURICH CH http://www.uzh.ch
5 partner TARTU ULIKOOL EE www.ut.ee
6 partner SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT CH www.swisstph.ch
7 partner ARISTOTELIO PANEPISTIMIO THESSALONIKIS EL www.auth.gr
8 partner UNIVERSITEIT ANTWERPEN BE www.uantwerpen.be
9 partner CHARITE - UNIVERSITAETSMEDIZIN BERLIN DE www.charite.de
10 partner Servicio Vasco de Salud Osakidetza ES http://www.osakidetza.euskadi.net/v19-oskhome/es/
11 partner STELLENBOSCH UNIVERSITY ZA
12 partner FONDAZIONE PENTA - FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV ANDRELATED DISEASES - ONLUS IT www.penta-id.org